Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)
China flag China · Delayed Price · Currency is CNY
10.89
-0.21 (-1.89%)
Sep 10, 2026, 3:04 PM CST

SHE:002923 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
13.47-63.4739.8866.9155.48139.77
Depreciation & Amortization
143.29143.15136.54112.8772.2363.7
Other Amortization
6.786.626.14.665.858.96
Loss (Gain) From Sale of Assets
-2.19-0.63--0.15-0.05-
Asset Writedown & Restructuring Costs
12.2216.780.430.150.330.23
Loss (Gain) From Sale of Investments
-0.37-0.19-0.090.36-0.1-0.41
Provision & Write-off of Bad Debts
3.31.170.140.162.560.49
Other Operating Activities
57.7456.8629.8258.5236.846.17
Change in Accounts Receivable
-59.53-55.8427.13-11.95-53.67-239.24
Change in Inventory
34.7226.28-9.5320.92-132.53-37.38
Change in Accounts Payable
-43.04-21.76-18.97-81.6249.69267.29
Change in Other Net Operating Assets
------6.7
Operating Cash Flow
167.67104.41211.19172.68135.01205.91
Operating Cash Flow Growth
21.34%-50.56%22.30%27.90%-34.43%-17.75%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-17.33-17.96-81.25-174.53-251.75-376.48
Sale of Property, Plant & Equipment
1.6---0.07-
Investment in Securities
-0-0-0-0.1344.43
Other Investing Activities
0.380.20.08---
Investing Cash Flow
-15.34-17.77-81.17-174.53-251.56-332.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-211.5853.89193.44234.43286
Long-Term Debt Repaid
--153.3-126.94-90.36-57.69-76.33
Lease Payments
-2.17-2.17-2.63-2.57-3.32-3.99
Net Debt Issued (Repaid)
-35.4158.27-73.05103.07176.74209.67
Repurchase of Common Stock
-----13.86-1.66
Common Dividends Paid
-12.47-64.09-84.7-102.38-89.68-82.65
Other Financing Activities
1.47-54.21--5.17-29.65
Financing Cash Flow
-46.41-60.02-157.75-4.4873.2155.01

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-2.170.382.430.41.37-0.59
Net Cash Flow
103.7526.99-25.3-5.93-41.9828.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
150.3486.44129.94-1.85-116.75-170.58
Free Cash Flow Growth
43.41%-33.47%----
Free Cash Flow Margin
11.24%7.35%10.99%-0.14%-8.51%-14.34%
Free Cash Flow Per Share
0.440.260.39-0.01-0.34-0.51
Levered Free Cash Flow
351.63110.1125.56-135.04-129.24-207.03
Unlevered Free Cash Flow
359.44118.3135.43-124.97-124.89-205.92
Free Cash Flow After Leases
148.1784.27127.31-4.42-120.07-174.56

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
81.3481.3477.3340.0881.2576.66
Change in Working Capital
-66.57-55.89-1.63-70.78-138.12-12.99